Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New molecular targets for cholesterol-lowering therapy.

N N Izzat1, M E Deshazer, D S Loose-Mitchell

  • 1Department of Integrative Biology and Pharmacology, University of Texas Health Sciences Center, Houston, Texas 77225, USA.

The Journal of Pharmacology and Experimental Therapeutics
|April 25, 2000
PubMed
Summary

Cholesterol-lowering statins significantly reduce cardiovascular and total mortality risk. New therapies targeting bile acid transport and cholesterol absorption offer additional strategies for managing cholesterol levels.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bile acid transport in hypercholesterolemic resistant rabbits.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2009
Same author

Renal function following cardiac arrest and resuscitation in the canine.

Resuscitation·1996
Same author

Transcriptional regulation of endothelial constitutive PGHS-1 expression by phorbol ester.

The American journal of physiology·1996
Same author

Development and use of a receptor antibody to characterize the interaction between somatostatin receptor subtype 1 and G proteins.

Molecular pharmacology·1995
Same author

Topology of prostaglandin H synthase-1 in the endoplasmic reticulum membrane.

Archives of biochemistry and biophysics·1995
Same author

Toxicity of endogenous and environmental estrogens: what is the role of elemental interactions?

Environmental health perspectives·1995

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Randomized clinical trials confirm that 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) reduce cardiovascular and total mortality.
  • Risk reduction is observed across diverse patient populations, including those with and without pre-existing cardiovascular disease or varying plasma cholesterol levels.

Purpose of the Study:

  • To review the established benefits of cholesterol-lowering therapies.
  • To identify and discuss novel molecular targets for future cholesterol-lowering drug development.

Main Methods:

  • Review of randomized clinical trials on statin efficacy.
  • Identification and description of emerging therapeutic targets, including the Na(+)-dependent bile acid transporter, cholesterol absorption pathways, and transcriptional regulation of cholesterol 7alpha-hydroxylase.

Related Experiment Videos

Main Results:

  • Statins effectively lower plasma cholesterol, slow atherosclerosis progression, and reduce ischemic events, potentially to levels below 100 mg/dl.
  • Novel targets offer alternative mechanisms for cholesterol reduction beyond statin pathways.

Conclusions:

  • Cholesterol-lowering treatment is a proven strategy for reducing mortality.
  • Emerging targets like the bile acid transporter and cholesterol absorption mechanisms present promising avenues for new therapeutic interventions.